000 | 01504 a2200421 4500 | ||
---|---|---|---|
005 | 20250516054208.0 | ||
264 | 0 | _c20120619 | |
008 | 201206s 0 0 eng d | ||
022 | _a1477-0970 | ||
024 | 7 |
_a10.1177/1352458511421920 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPaz Soldán, M Mateo | |
245 | 0 | 0 |
_aStatin therapy and multiple sclerosis disability in a population-based cohort. _h[electronic resource] |
260 |
_bMultiple sclerosis (Houndmills, Basingstoke, England) _cMar 2012 |
||
300 |
_a358-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aDisability Evaluation |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMinnesota |
650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSeverity of Illness Index |
700 | 1 | _aPittock, Sean J | |
700 | 1 | _aWeigand, Stephen D | |
700 | 1 | _aYawn, Barbara P | |
700 | 1 | _aRodriguez, Moses | |
773 | 0 |
_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 18 _gno. 3 _gp. 358-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1352458511421920 _zAvailable from publisher's website |
999 |
_c21148387 _d21148387 |